2026021050 — GYC/GGpeps Tirzepatide
Vendor COAGYC/GGpeps | Tirzepatide, last activity 1 month ago
8 related batch concerns · 1 mention
Get notified when a lab result is posted, a group test forms, or this batch is flagged by the community.
Test Results
The label says 50 mg. Janoshik weighed 55.2 mg — 10% more than the label. Your dose depends on what is really in the vial, so the steps below use the measured amount.
Draw
18 units
on a U-100 insulin syringe, for 5 mg
Going by the label you would draw 20 units — which from this vial is actually 5.52 mg, not 5 mg.
- The vial holds dry powder: 55.2 mg of Tirzepatide, as weighed.
- Water spreads that powder evenly through the liquid: 55.2 mg ÷ 2 ml = 27.6 mg per ml.
- An insulin syringe counts in units, 100 to the ml, so each unit carries 276 mcg.
- Your dose divided by that: 5 mg ÷ 276 mcg = 18 units.
The water changes how many units a dose takes, never how much peptide you get. Twice the water means twice the units for the same dose. What sets the dose is how much is in the vial — which is why the measured amount matters.
Arithmetic, not medical advice. Assumes a U-100 syringe and that the powder fully dissolves. The figure is from the vial that was tested; yours is from the same lot but was not weighed itself.
Related batches
5 of 5 tested
same lot series
Endotoxin levels have exceeded the 10 EU/vial working limit in two independent Janoshik tests (17.116 and 47.923…
same lot series
2 community mentions, no summary yet
Retatrutide, same vendor
This batch has endotoxin at 57.403 EU/vial per the vendor's Janoshik certificate—over five times the 10 EU/vial working…
SPB
SPB rarely publishes certificates, and this batch has two quality concerns reported against it
same lot series
1 community mention, no summary yet
Community Intelligence
- 1 concern report involving 2026061030
- 2 concern reports involving 2026041210
- 1 concern report involving 2026091215
- 1 concern report involving 2026061215
- 1 concern report involving 2026031310
- 2 concern reports involving 2026071210
- 1 concern report involving 2026071220
- 2 concern reports involving SN26XY-1-02
Reported against other GYC/GGpeps Tirzepatide batches, not this one.
Also known as: 202602-1050
Activity
Hello! Warm greetings from GYC team! 🎁Welcome GYC the 21th Customer Appreciation Day ! 🎁 This is our way of saying “we see you, we appreciate you, and we want to give back” for every trust you’ve...
Vendor
GYC/GGpeps